April 20 (Reuters) - Moderna Inc said on Tuesday it had secured a new COVID-19 vaccine supply agreement with Israel for 2022, under which the country has the option to buy doses of one of the company’s variant-specific vaccine candidates.
The announcement follows two earlier agreements between Israel and Moderna to supply a total of 10 million doses of the COVID-19 vaccine.
Moderna’s COVID-19 booster vaccine is in early-stage trials. The company in April said it should be able to provide a booster shot for protection against variants of the novel coronavirus by the end of this year.
Israel has agreed with Pfizer Inc and Moderna to buy 16 million more vaccine doses for the country’s 9.3 million population, Prime Minister Benjamin Netanyahu said in televised remarks on Tuesday. (Reporting by Dania Nadeem in Bengaluru; Editing by Arun Koyyur and Ramakrishnan M.)